4PL/LLP: The model of the future for the life sciences industry?

Globalization, enlarged product portfolios due to acquisitions as well as new requirements regarding products and services have dramatically changed the supply chains of the life sciences industry in recent years. In addition, digitalization opens up new opportunities, but also creates major challenges for life sciences logistics. Against this backdrop, the question of whether to ‘make or buy’ logistics services gains new significance. Which processes should a life sciences company carry out itself and which should be assigned to external service providers? For some time already, an increasing demand for the identification of the scope of service and the selection of fourth party logistics (4PL) and lead logistics providers (LLP) has been noticeable in the life sciences industry. As well as for the traditional subjects of storage and transport, companies are increasingly on the lookout for process expertise and innovative IT solutions, which are associated with 4PL and LLP. In its latest PHARMA Management Radar study, consulting specialist CAMELOT Management Consultants sheds light on the collaboration of life sciences companies with 4PL and LLP service providers and highlights current logistics outsourcing trends in the life sciences industry. This article outlines the key findings of the study.

https://www.ecv.de/beitrag/pharmind/4PLLLP_The_model_of_the_future_for_the_life_sciences_industry